Evidence map›Paper›PMID 27684489›Full record

ArticleClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2017

Immunoproteomic analysis of house dust mite antigens reveals distinct classes of dominant T cell antigens according to function and serological reactivity.

Carla Oseroff, Lars H Christensen, Luise Westernberg, John Pham, Jerome Lane, Sinu Paul, Jason Greenbaum, Thomas Stranzl, Gitte Lund, Ilka Hoof and 8 more

Open access · greenAbstract read
In one paragraph

Article in Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. The association of allergic sensitization patterns in early childhood with disease manifestations and immunological reactivity at 10 years of age.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2019
    Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 2 countries.

Carla Oseroff *La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA.
Lars H Christensen *ALK-Abelló A/S, Global Research, Hørsholm, Denmark.
Luise WesternbergLa Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA.
John PhamLa Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA.
Jerome LaneLa Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA.
Sinu PaulLa Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA.
Jason GreenbaumLa Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA.
Thomas StranzlALK-Abelló A/S, Global Research, Hørsholm, Denmark.
Gitte LundALK-Abelló A/S, Global Research, Hørsholm, Denmark.
Ilka HoofALK-Abelló A/S, Global Research, Hørsholm, Denmark.
Jens HolmALK-Abelló A/S, Global Research, Hørsholm, Denmark.
Peter A WürtzenALK-Abelló A/S, Global Research, Hørsholm, Denmark.
Kåre H MenoALK-Abelló A/S, Global Research, Hørsholm, Denmark.
April FrazierLa Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA.
Veronique SchultenLa Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA.
Peter S AndersenALK-Abelló A/S, Global Research, Hørsholm, Denmark.
Bjoern PetersLa Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA.
Alessandro SetteLa Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA.
La Jolla Institute for Immunology · USALK-Abelló (Denmark) · DK

Funding

Understanding mechanisms in specific immunotherapy (SIT)U19AI100275 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI SETTE, ALESSANDRO · 2012 to 2017
$8.1M
HEPATITIS C VIRAL MUTANTS AND HUMAN T CELL FUNCTIONK01DK002970 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI WANG, HUIRU · 2001 to 2003
$265k
NIAID NIH HHS U19 AI100275NIDDK NIH HHS K01 DK002970
6 · The paper itself

Abstract

backgroundHouse dust mite (HDM) allergens are a common cause of allergy and allergic asthma. A comprehensive analysis of proteins targeted by T cells, which are implicated in the development and regulation of allergic disease independent of their antibody reactivity, is still lacking.

objectiveTo comprehensively analyse the HDM-derived protein targets of T cell responses in HDM-allergic individuals, and investigate their correlation with IgE/IgG responses and protein function.

methodsProteomic analysis (liquid chromatography-tandem mass spectrometry) of HDM extracts identified 90 distinct protein clusters, corresponding to 29 known allergens and 61 novel proteins. Peripheral blood mononuclear cells (PBMC) from 20 HDM-allergic individuals were stimulated with HDM extracts and assayed with a set of ~2500 peptides derived from these 90 protein clusters and predicted to bind the most common HLA class II types. 2D immunoblots were made in parallel to elucidate IgE and IgG reactivity, and putative function analyses were performed in silico according to Gene Ontology annotations.

resultsAnalysis of T cell reactivity revealed a large number of T cell epitopes. Overall response magnitude and frequency was comparable for known and novel proteins, with 15 antigens (nine of which were novel) dominating the total T cell response. Most of the known allergens that were dominant at the T cell level were also IgE reactive, as expected, while few novel dominant T cell antigens were IgE reactive. Among known allergens, hydrolase activity and detectable IgE/IgG reactivity are strongly correlated, while no protein function correlates with immunogenicity of novel proteins. A total of 106 epitopes accounted for half of the total T cell response, underlining the heterogeneity of T cell responses to HDM allergens. CONCLUSIONS AND CLINICAL RELEVANCE: Herein, we define the T cell targets for both known allergens and novel proteins, which may inform future diagnostics and immunotherapeutics for allergy to HDM.

Indexed as

ProteomeProteomicsAllergensAmino Acid SequenceAntibody SpecificityAntigens, DermatophagoidesComputational BiologyEpitopes, T-LymphocyteHistocompatibility Antigens Class IIHumansHypersensitivityImmunodominant EpitopesImmunoglobulin EImmunoglobulin GLeukocytes, MononuclearT-LymphocytesAllergensAntigens, DermatophagoidesEpitopes, T-LymphocyteHistocompatibility Antigens Class IIImmunodominant EpitopesImmunoglobulin EImmunoglobulin GProteomeallergenshouse dust miteproteomicsT cell epitopes

Identifiers

PMID27684489
PMCPMC5374056
OpenAlexW2524345511

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.